Читать книгу Intracranial Gliomas Part III - Innovative Treatment Modalities - Группа авторов - Страница 27

1Keles GE, Anderson B, Berger MS: The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 1999;52:371–379.

2Kostron H, Obwegeser A, Jakober R: Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B 1996;36:157–168.

3Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q: Photodynamic therapy. J Natl Cancer Inst 1998;90:889–905.

4Stylli SS, Kaye AH: Photodynamic therapy of cerebral glioma – a review. Part I – a biological basis. J Clin Neurosci 2006;13:615–625.

5Stylli SS, Kaye AH: Photodynamic therapy of cerebral glioma – a review. Part II – clinical studies. J Clin Neurosci 2006;13:709–717.

6Eljamel S: Photodynamic applications in brain tumors: a comprehensive review of the literature. Photodiagnosis Photodyn Ther 2010;7:76–85.

7Bechet D, Mordon SR, Guillemin F, Barberi-Heyob MA: Photodynamic therapy of malignant brain tumours: a complementary approach to conventional therapies. Cancer Treat Rev 2014;40:229–241.

8Quirk BJ, Brandal G, Donlon S, Vera JC, Mang TS, Foy AB, Lew SM, Girotti AW, Jogal S, LaViolette PS, Connelly JM, Whelan HT: Photodynamic therapy (PDT) for malignant brain tumors – where do we stand? Photodiagnosis Photodyn Ther 2015;12:530–544.

9Kaneko S: [Intraoperative photodynamic diagnosis of human glioma using ALA induced protoporphyrin IX]. No Shinkei Geka 2001;29:1019–1031 (in Japanese).

10Kaneko S: [Photodynamic diagnosis and photodynamic therapy for malignant glioma under awake surgery]. J Iwamizawa Municipal General Hospital 2004;30:1–13 (in Japanese).

11Kaneko S: [Fluorescence diagnosis and photodynamic therapy using two types of photosensitizer]; in Miyoshi N, Kaneko S (eds): Recent Progress on Clinical and Basic Research of ALA. Sapporo, Kashiwaba Neurosurgical Hospital, 2005, pp 17–24 (in Japanese).

12Kaneko S: A current overview: photodynamic diagnosis and photodynamic therapy using 5-aminolevulinic acid in neurosurgery. J Jpn Soc Laser Surg Med (JJSLSM) 2008;29:135–146.

13Kaneko S: Recent advances in PDD and PDT for malignant brain tumors; in Proceedings of the 6th Asian Pacific Laser Symposium, January 30 – February 1, 2008, Nagoya, Japan.

14Kaneko S, Kondo M: Photodynamic medicine in malignant glioma – the reason why ALA induced PpIX is accumulated; in Proceedings of the 7th International Symposium on Photodynamic Therapy and Photodiagnosis in Clinical Practice, October 7–11, 2008, Brixen/Bressanone, Italy.

15Kaneko S: [Photodynamic applications (PDD, PDT) using aminolevulinic acid in neurosurgery]; in Okura I, Tanaka T (eds): Aminolevulinic Acid: Science, Technology and Applications. Tokyo, SBI ALApromo, Tokyo Institute of Technology Press, 2011, pp 119–140 (in Japanese).

16Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH: Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci 2004;11:584–596.

17Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–401.

18Stepp H, Beck T, Pongratz T, Meinel T, Kreth FW, Tonn JCh, Stummer W: ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. J Environ Pathol Toxicol Oncol 2007;26:157–164.

19Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, Stummer W, Baumgartner R: Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 2007;39:386–393.

20Stepp H: ALA for stereotactic interstitial PDT of malignant glioma; in Program of the 2nd International ALA and porphyrin symposium (IAPS2). November 15–16, 2014, Tokyo, Japan.

21Bisland SK, Lilge L, Lin A, Rusnov R, Wilson BC: Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol 2004;80:22–30.

22Diamond I, Granelli SG, McDonagh AF, Nielsen S, Wilson CB, Jaenicke R: Photodynamic therapy of malignant tumours. Lancet 1972;2:1175–1177.

23Perria C, Capuzzo T, Cavagnaro G, Datti R, Francaviglia N, Rivano C, Tercero VE: Fast attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 1980;24:119–129.

24Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P: Photodynamic therapy of high grade glioma – long term survival. J Clin Neurosci 2005;12:389–398.

25Popovic EA, Kaye AH, Hill JS: Photodynamic therapy of brain tumors. Semin Surg Oncol 1995;11:335–345.

26Rosenthal MA, Kavar B, Uren S, Kaye AH: Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin. J Clin Neurosci 2003;10:425–427.

27Kostron H, Fiegele T, Akatuna E: Combination of Foscan^® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors. Med Laser Appl 2006;21:285–290.

28Muller PJ, Wilson BC: Photodynamic therapy of brain tumors – a work in progress. Lasers Surg Med 2006;38:384–389.

29Eljamel MS, Goodman C, Moseley H: ALA and Photofrin^® fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre phase III randomised controlled trial. Lasers Med Sci 2008;23:361–367.

30Akimoto J, Haraoka J, Aizawa K: Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. Photodiagnosis Photodyn Ther 2012;9:91–99.

31Muragaki Y, Akimoto J, Maruyama T, Iseki H, Ikuta S, Nitta M, Maebayashi K, Saito T, Okada Y, Kaneko S, Matsumura A, Kuroiwa T, Karasawa K, Nakazato Y, Kayama T: Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg 2013;119:845–852.

32Olson JJ, Ryken T: Guidelines for the treatment of newly diagnosed glioblastoma: introduction. J Neurooncol 2008;89:255–258.

33Muller P, Wilson B: A randomized two arm clinical trial of photophrin PDT and standard therapy in high grade gliomas – phase III trial; in Proceedings of the 6th International Symposium on Photodynamic Diagnosis and Therapy in Clinical Practice, October 10–14, 2006, Brixen/Bressanone, Italy.

34Regula J, MacRobert AJ, Gorchein A, Buonaccorsi GA, Thorpe SM, Spencer GM, Hatfield AR, Bown SG: Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX – a pilot study. Gut 1995;36:67–75.

35Kaye AH, Morstyn G, Brownbill D: Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1–2 study. J Neurosurg 1987;67:500–505.

36Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT: Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol 2004;67:201–207.

37Krishnamurthy S, Powers SK, Witmer P, Brown T: Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med 2000;27:224–234.

Sadao Kaneko, MD

Chief Director, Kashiwaba Neurosurgical Hospital

1-15-7-20, Tsukisamu-Higashi, Toyohira-ku

Sapporo, Hokkaido 062-8513 (Japan)

E-Mail srkaneko@seagreen.ocn.ne.jp